ACOT1 Antibodies

Santa Cruz Biotechnology provides a broad selection of ACOT1 monoclonal antibodies for research focused on understanding acyl-CoA thioesterases. ACOT1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACOT1, or acyl-CoA thioesterase 1, plays a crucial role in lipid metabolism by hydrolyzing acyl-CoA thioesters, thereby regulating fatty acid availability and signaling pathways. ACOT1 maintains cellular energy homeostasis and has significant implications in metabolic disorders and cancer. Research has shown that ACOT1 expression levels vary across different tissues and can be regulated by metabolic states. Scientists have identified multiple regulatory mechanisms controlling ACOT1 activity, highlighting its importance in cellular metabolism. Understanding ACOT1 function continues to reveal potential therapeutic targets for various diseases. Recent studies have demonstrated ACOT1's involvement in inflammation and immune response pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of lipid metabolism and its impact on human health.